Genovis Q3 2024: Initial take – Stronger than anticipated - Redeye

Redeye provides its initial take on Genovis' Q3 report, which exceeded expectations across the board. We anticipate a positive relief in the share price, accompanied by upward estimate revisions following today's report.

Länk till analysen i sin helhet: https://www.redeye.se/research/1051370/genovis-q3-2024-initial-take-stronger-than-anticipated?utm_source=finwire&utm_medium=RSS